MARKET

CODX

CODX

Co-Diagnostics Inc
NASDAQ
1.290
+0.110
+9.32%
After Hours: 1.290 0 0.00% 19:48 12/01 EST
OPEN
1.160
PREV CLOSE
1.180
HIGH
1.339
LOW
1.150
VOLUME
81.27K
TURNOVER
0
52 WEEK HIGH
3.330
52 WEEK LOW
0.9750
MARKET CAP
39.45M
P/E (TTM)
-0.8922
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CODX last week (1120-1124)?
Weekly Report · 11/27 12:11
Weekly Report: what happened at CODX last week (1113-1117)?
Weekly Report · 11/20 12:07
HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Raises Price Target to $3
Benzinga · 11/13 15:43
Weekly Report: what happened at CODX last week (1106-1110)?
Weekly Report · 11/13 11:58
Hold Rating on Co-Diagnostics: Revenue Decline Offset by Grant, FDA Submission on the Horizon, and Strong Cash Position Amid Potential Risks
TipRanks · 11/13 11:40
Co-Diagnostics Inc: Current report
Press release · 11/09 22:00
Co-Diagnostics Inc: Quarterly report
Press release · 11/09 22:00
Co-Diagnostics Q3 2023 Gaap EPS $(0.20) Beats $(0.29) Estimate, Sales $2.46M Beat $200.00K Estimate
Co-diagnostics reported quarterly losses of $0.20 per share. This is a 400 percent decrease from the same period last year. The company reported quarterly sales of $2.46 million which beat the analyst consensus estimate of $200.00 million by 1.13%.
Benzinga · 11/09 21:59
More
About CODX
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. It also uses its technology to design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. It also sells diagnostic equipment from other manufacturers as self-contained lab systems. The Company is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Webull offers Co-Diagnostics Inc stock information, including NASDAQ: CODX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CODX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CODX stock methods without spending real money on the virtual paper trading platform.